Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society

peer reviewed ; Background: Few studies thus far have compared head-to-head different non-myelooablative conditioning regimens for allogeneic hematopoietic cell transplantation (allo-HCT). Methods: Here, we report the results of a phase II multicenter randomized study comparing non-myeloablative allo-HCT from HLA-identical siblings (n = 54) or from 10/10 HLA-matched unrelated donors (n = 40) with either fludarabine plus 2 Gy total body irradiation (Flu-TBI arm; n = 49) or 8 Gy TLI + anti-thymocyte globulin (TLI-ATG arm; n = 45) conditioning. Results: The 180-day cumulative incidences of grade... Mehr ...

Verfasser: Baron, Frédéric
Zachée, Pierre
Maertens, Johan
Kerre, Tessa
ORY, Aurélie
SEIDEL, Laurence
Graux, Carlos
Lewalle, Philippe
Van Gelder, Michel
Theunissen, Koen
WILLEMS, Evelyne
Emonts, Marie-Paule
De Becker, Ann
Beguin, Yves
Dokumenttyp: journal article
Erscheinungsdatum: 2015
Verlag/Hrsg.: BioMed Central
Schlagwörter: allo-HCT / non-myeloablative conditioning / TBI / TLI / ATG / GVHD / graft-versus-leukemia effects / Human health sciences / Hematology / Sciences de la santé humaine / Hématologie
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26513511
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://orbi.uliege.be/handle/2268/177557